z-logo
Premium
Back cover: Casein glycomacropeptide‐derived peptide IPPKKNQDKTE ameliorates high glucose‐induced insulin resistance in HepG2 cells via activation of AMPK signaling
Author(s) -
Song Jiajia,
Wang Qian,
Du Min,
Li Tiange,
Chen Bin,
Mao Xueying
Publication year - 2017
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.201770024
Subject(s) - ampk , protein kinase b , insulin resistance , insulin receptor substrate , insulin receptor , phosphorylation , medicine , gluconeogenesis , chemistry , protein kinase a , amp activated protein kinase , insulin , endocrinology , glycogen , irs1 , biochemistry , biology , enzyme
Mol. Nutr. Food Res . 2017, 61 , 1600301. DOI: 10.1002/mnfr.201600301 The glycomacropeptide (GMP)‐derived peptide IPPKKNQDKTE activates the insulin receptor substrate (IRS)/protein kinase B (Akt) signaling pathway by increasing phosphorylation levels of AMP‐activated protein kinase (AMPK) in high‐glucose‐induced insulin resistant HepG2 cells. This ultimately modulates high‐glucose‐induced abnormal gluconeogenesis and glycogen synthesis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here